Literature DB >> 3722422

Distribution of immunoglobulin G subclasses in anti-A and anti-B sera.

L A Kay, D Locke.   

Abstract

Sera from 117 immunologically normal subjects, who had been selected for the presence of high titre ABO system antibody on routine screening, were further evaluated for the presence of IgG and its subclasses IgG1, IgG2, IgG3, and IgG4 using an indirect antihuman globulin technique. Subjects of all ABO groups had the capacity to produce IgG antibodies within each subclass, but those of group O produced the broadest spectrum of IgG subclasses and greatest strength of reactions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722422      PMCID: PMC499995          DOI: 10.1136/jcp.39.6.684

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  Pathogenesis of ABO hemolytic disease.

Authors:  A S WIENER; V J FREDA; I B WEXLER; G J BRANCATO
Journal:  Am J Obstet Gynecol       Date:  1960-03       Impact factor: 8.661

2.  Studies of blood group antibodies. IV. Physicochemical differences between isoanti-A,B and isoanti-A or isoanti-B.

Authors:  A J RAWSON; N M ABELSON
Journal:  J Immunol       Date:  1960-12       Impact factor: 5.422

3.  Isoagglutinins associated with ABO erythroblastosis.

Authors:  S KOCHWA; R E ROSENFIELD; L TALLAL; L R WASSERMAN
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

4.  Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents.

Authors:  M Contreras; S E Armitage; P E Hewitt
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

5.  Cellular basis of immune response to antigens of ABO blood-group system. Capacity to provide help during response to T-cell-dependent ABO-system antigens is restricted to individuals of blood group O.

Authors:  L A Kay
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

6.  Subclass restriction of murine anti-carbohydrate antibodies.

Authors:  R M Perlmutter; D Hansburg; D E Briles; R A Nicolotti; J M Davie
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

  6 in total
  1 in total

1.  Outcomes of ABO-incompatible kidney transplantation in the United States.

Authors:  John R Montgomery; Jonathan C Berger; Daniel S Warren; Nathan T James; Robert A Montgomery; Dorry L Segev
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.